Anixa Biosciences Inc (ANIX)
2.99
-0.10
(-3.24%)
USD |
NASDAQ |
May 02, 16:00
2.985
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2023 | 0.00 |
| January 31, 2023 | 0.00 |
| October 31, 2022 | 0.00 |
| July 31, 2022 | 0.00 |
| April 30, 2022 | 0.00 |
| January 31, 2022 | 0.00 |
| October 31, 2021 | 0.00 |
| July 31, 2021 | 0.00 |
| April 30, 2021 | 0.00 |
| January 31, 2021 | 0.00 |
| October 31, 2020 | 0.00 |
| July 31, 2020 | 0.00 |
| April 30, 2020 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
| July 31, 2018 | 0.00 |
| April 30, 2018 | 0.00 |
| January 31, 2018 | 0.00 |
| October 31, 2017 | 0.00 |
| July 31, 2017 | 0.3644 |
| April 30, 2017 | 0.8358 |
| Date | Value |
|---|---|
| January 31, 2017 | -0.7856 |
| October 31, 2016 | 0.00 |
| July 31, 2016 | 0.00 |
| April 30, 2016 | 0.00 |
| January 31, 2016 | 0.00 |
| October 31, 2015 | 0.00 |
| July 31, 2015 | 0.00 |
| April 30, 2015 | 0.00 |
| January 31, 2015 | 0.00 |
| October 31, 2014 | 0.00 |
| July 31, 2014 | 45.13 |
| April 30, 2014 | -1.368 |
| January 31, 2014 | -1.266 |
| October 31, 2013 | -1.671 |
| July 31, 2013 | -1.684 |
| April 30, 2013 | -3.771 |
| January 31, 2013 | -4.084 |
| October 31, 2012 | -4.214 |
| July 31, 2012 | 0.00 |
| April 30, 2012 | 0.00 |
| January 31, 2012 | 0.00 |
| October 31, 2011 | 0.00 |
| July 31, 2011 | 0.00 |
| April 30, 2011 | 0.00 |
| January 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jul 2019
--
Maximum
Jul 2019
--
Average
--
Median
Jul 2019
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 25.37M |
| Total Liabilities (Quarterly) | 1.768M |
| Shareholders Equity (Quarterly) | 24.60M |